Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass

PHASE1RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

December 1, 2026

Conditions
Cardiopulmonary BypassAKI - Acute Kidney Injury
Interventions
DRUG

Methylprednisolone group

In this study patients will be given a single intra-venous dose of methylprednisolone (2 mg/kg) after the induction of anesthesia, and before the initiation of CPB.

Trial Locations (1)

00202

RECRUITING

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER